Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter A Vriesendorp

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|October 28, 2023
The incidence and consequent relevance of unplanned invasive coronary angiography following coronary artery bypass graftingSamuel Heuts, Pieter A Vriesendorp
Journal of the American College of Cardiology|July 22, 2017
Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Word of EndorsementMax Liebregts, Pieter A Vriesendorp, Jurrien M Ten Berg
Heart (British Cardiac Society)|June 11, 2025
When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantationSamuel Heuts, Michal J Kawczynski, Bart Maesen, et al.
Lancet (London, England)|March 8, 2023
Revascularisation in acute coronary syndromes: change in practice?Tobias F S Pustjens, Pieter A Vriesendorp, Arnoud W J Van't Hof
JACC. Heart Failure|October 12, 2015
A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic CardiomyopathyMax Liebregts, Pieter A Vriesendorp, Bakhtawar K Mahmoodi, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 20, 2026
A Multidisciplinary Approach for Safe Transfemoral Transcatheter Aortic Valve Implantation in Patients with High Risk Features for Access ComplicationsReinier R Smeets, Anna Prent, Bart Maesen, et al.
Circulation. Heart Failure|July 24, 2012
Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysisArend F L Schinkel, Pieter A Vriesendorp, Eric J G Sijbrands, et al.
Clinical Cardiology|July 22, 2014
Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathyPieter A Vriesendorp, Arend F L Schinkel, Natasja M S de Groot, et al.
Heart, Lung & Circulation|July 10, 2021
Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Public and Private Hospital Settings: A Propensity-Matched AnalysisPieter A Vriesendorp, Shane Nanayakkara, Joshua Bowditch, et al.
The American Journal of Cardiology|August 1, 2016
Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic CardiomyopathyHannah G van Velzen, Pieter A Vriesendorp, Rogier A Oldenburg, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
The Journal of Thoracic and Cardiovascular Surgery|October 28, 2023
The incidence and consequent relevance of unplanned invasive coronary angiography following coronary artery bypass graftingSamuel Heuts, Pieter A Vriesendorp
Journal of the American College of Cardiology|July 22, 2017
Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Word of EndorsementMax Liebregts, Pieter A Vriesendorp, Jurrien M Ten Berg
Heart (British Cardiac Society)|June 11, 2025
When absence of evidence equates to evidence of absence: the case of routine use of cerebral embolic protection devices in transcatheter aortic valve implantationSamuel Heuts, Michal J Kawczynski, Bart Maesen, et al.
Lancet (London, England)|March 8, 2023
Revascularisation in acute coronary syndromes: change in practice?Tobias F S Pustjens, Pieter A Vriesendorp, Arnoud W J Van't Hof
JACC. Heart Failure|October 12, 2015
A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic CardiomyopathyMax Liebregts, Pieter A Vriesendorp, Bakhtawar K Mahmoodi, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 20, 2026
A Multidisciplinary Approach for Safe Transfemoral Transcatheter Aortic Valve Implantation in Patients with High Risk Features for Access ComplicationsReinier R Smeets, Anna Prent, Bart Maesen, et al.
Circulation. Heart Failure|July 24, 2012
Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysisArend F L Schinkel, Pieter A Vriesendorp, Eric J G Sijbrands, et al.
Clinical Cardiology|July 22, 2014
Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathyPieter A Vriesendorp, Arend F L Schinkel, Natasja M S de Groot, et al.
Heart, Lung & Circulation|July 10, 2021
Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Public and Private Hospital Settings: A Propensity-Matched AnalysisPieter A Vriesendorp, Shane Nanayakkara, Joshua Bowditch, et al.
The American Journal of Cardiology|August 1, 2016
Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic CardiomyopathyHannah G van Velzen, Pieter A Vriesendorp, Rogier A Oldenburg, et al.
Pageof 4